BioViotica

(R)-Semivioxanthin

CHF 150.00

In stock

BVT-0360-C500500 µgCHF 150.00

BVT-0360-M0011 mgCHF 250.00

More Information
Product Details
Synonyms	(R)-9,10-Dihydroxy-7-methoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-1-one
Product Type	Chemical
Properties
Formula	C₁₅H₁₄O₅
MW	274.3
CAS	70477-26-8
Source/Host Chemicals	Isolated from Penicillium citreo-viride.
Purity Chemicals	≥98% (HPLC)
Appearance	Pale yellow to green solid.
Solubility	Soluble in chloroform, tetrahydrofuran or DMSO; poorly soluble in water.
Identity	Determined by ¹H-NMR.
Declaration	Manufactured by BioViotica.
InChi Key	BWNCKEBBYADFPQ-SSDOTTSWSA-N
Smiles	COC1=CC(O)=C2C(O)=C3C(=O)O[C@H](C)CC3=CC2=C1
Shipping and Handling
Shipping	AMBIENT
Short Term Storage	+4°C
Long Term Storage	-20°C
Use/Stability	Stable for at least 1 year after receipt when stored at -20°C. After reconstitution protect from light at -20°C.
Documents
MSDS	Download PDF
Product Specification Sheet
Datasheet	Download PDF

Description

Mycotoxin.
Antibacterial (Gram-positive) and antifungal.
Immunoregulator by degradation of IκB (Inhibitor of NF-κB) and regulation of the TNF-α (tumor necrosis factor-α) and MAPK (mitogen-activated protein kinase) signaling pathways.

Product References

Isolierung des Antibioticums semi-Vioxanthin aus Penicillium citreo-viride und Synthese des Xanthomegnins: A. Zeeck, et al.; Chem. Ber. 112, 957 (1979)
Total synthesis of (R)- and (S)-semi-vioxanthin: D.Drochner & M. Müller; Eur. J. Org. Chem. 2001, 211 (2001)
Semi-vioxanthin isolated from marine-derived fungus regulates tumor necrosis factor-alpha, cluster of differentiation (CD) 80, CD86, and major histocompatibility complex class II expression in RAW264.7 cells via nuclear factor-kappaB and mitogen-activated: X.Y. Yang, et al.; Biol. Pharm. Bull. 31, 2228 (2008)

Call	+41 61 926 6040
Fax	+41 61 926 6049